Vivos Therapeutics, Inc. Quarterly Share-based Payment Arrangement, Expense in USD from Q1 2022 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Vivos Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q1 2022 to Q3 2024.
  • Vivos Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $100K, a 50% decline year-over-year.
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $100K -$100K -50% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-14
Q2 2024 $300K -$100K -25% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-14
Q3 2023 $200K Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-14
Q2 2023 $400K Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-14
Q1 2023 $500K +$300K +150% Jan 1, 2023 Mar 31, 2023 10-Q 2023-06-08
Q1 2022 $200K Jan 1, 2022 Mar 31, 2022 10-Q/A 2022-11-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.